Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
OCTOBER 2021LIFE SCIENCES REVIEW6The pandemic has ushered in a new era of genomic surveillance, in which scientists are following viral genetic alterations at a never-before-seen speed and scale. Scientists have discovered several fast-spreading and new variants in recent months, prompting regulatory restrictions in a number of nations. Over the years, genomic research has helped forecast illness risk, generate novel therapies, and advance our clinical environment. Individual genetic data holds the key to predicting and treating disease in clinical medicine in the future. Our genetic variation biomarkers are the key to new genetic advances and research that is currently underway. Although our understanding of genomes is far from comprehensive, a growing body of evidence shows that even our modest genetic knowledge can be significant in the field. With advances in gene regulation, genetic sequencing, and human genome research, the stage is set to improve human health. Genome sequencing is increasingly playing a major role in cancer stratification, identifying genetic diseases, and predicting a patient's potential therapy response. Keeping all of these genetic industry trends in mind, many organizations are working on newer and more sophisticated technologies.At this juncture, there is a wide variety of genomics solution providers entering the industry with a set of advanced and integrated offerings. On this note, we hope this edition will provide you with the right assistance in choosing the best genomics solution providers and service companies that will help you stay at the forefront of innovation. This insightful issue explores the varied solutions and services offered by leading genomics solution providers, along with insights from industry experts that will help you anchor a competitive edge in the genomics continuum.Let us know your thoughts.EDITORIALEnhancing Life with Genomics at the ForefrontCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Contact Us:Phone:510-230-0395Fax:510-894-8405Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com October - 01 - 2021, Vol 02, Issue - 09 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald Donovan*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comAsher Blake
< Page 5 | Page 7 >